Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II).
about
Coronary revascularization in the elderly with stable anginaIs the advantage of coronary bypass graft surgery over percutaneous coronary intervention in diabetic patients with severe multivessel disease influenced by the status of insulin requirement?Impact of incomplete surgical revascularization on survivalHas the difference in mortality between percutaneous coronary intervention and coronary artery bypass grafting in people with heart disease and diabetes changed over the years? A systematic review and meta-regressionCost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspectiveComposite outcomes in coronary bypass surgery versus percutaneous intervention.Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention: a cohort studyComparative effectiveness of coronary artery bypass grafting and percutaneous coronary intervention for multivessel coronary disease in a community-based population with chronic kidney disease.Coronary revascularization in diabetic patients: Current state of evidence.Analysis of the bypass angioplasty revascularization investigation trial using a multistate model of clinical outcomes.Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trialsLong-term mortality of coronary artery bypass grafting and bare-metal stenting.The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry.The application of walking training in the rehabilitation of patients after coronary artery bypass grafting.Myocardial revascularization: surgery or stenting?Potential shift from coronary bypass surgery to percutaneous coronary intervention for multivessel disease and its economic impact in the drug-eluting stent era.Long-term mortality of coronary artery bypass graft surgery and stenting with drug-eluting stentsMultivessel disease: percutaneous coronary intervention for classic coronary artery bypass grafting indications.Revascularization treatment of stable coronary artery disease.2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and InterventiPercutaneous versus surgical interventions for coronary artery disease in those with diabetes mellitus.Comparative effectiveness of revascularization strategies in stable ischemic heart disease: current perspective and literature review.Revascularization strategies in patients with Type 2 diabetes mellitus.Surgical versus percutaneous revascularization in patients with multivessel coronary artery disease.Bypass grafting versus percutaneous intervention in multivessel coronary disease: the current state.Comparison of coronary artery bypass graft surgery and percutaneous coronary intervention in patients with diabetes.Understanding the Outcome of Randomized Trials with Drug-Eluting Stents and Coronary Artery Bypass Graft in Patients with Multivessel Disease: A Review of a 25-Year Journey.Revascularization Strategies in Patients with Diabetes Mellitus and Acute Coronary Syndrome.Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease.Angina and associated healthcare costs following percutaneous coronary intervention: A real-world analysis from a multi-payer database.Description of a Heart Team approach to coronary revascularization and its beneficial long-term effect on clinical events after PCI.PCI or CABG: which patients and at what cost?Outcome after coronary artery bypass grafting and percutaneous coronary intervention in patients with stage 3b-5 chronic kidney disease.Drug-eluting stents in multivessel coronary artery disease: cost effectiveness and clinical outcomes.Short, Intermediate and long term outcomes of CABG vs. PCI with DES in Patients With Multivessel Coronary Artery Disease. Meta-Analysis of Six Randomized Controlled TrialsChanges in the safety paradigm with percutaneous coronary interventions in the modern era: Lessons learned from the ASCERT registry.Revascularization treatment in patients with coronary artery diseaseOutcomes from patients with multi-vessel disease following primary PCI: staged PCI imparts very low mortality.Management of multivessel coronary disease: let us not shortchange drug-eluting stents.Randomized trials of PCIs versus CABG surgery: why coronary stenting should remain the first choice of revascularization in non-diabetic patients and why the controversy is still present in diabetics.
P2860
Q26778104-37F86643-AD48-4289-BE8A-D60D148FEE42Q27013126-F7B6152E-D51C-4B1E-8778-7B4F90608760Q27023988-186647F9-F1F5-46F3-8268-7D8032F99202Q28079800-3FD230CC-D431-482B-93F3-04CA2BCD4137Q28269638-8477ABE4-6CF8-40DE-8F67-85CCF0487D88Q33924170-0CA66974-84F0-4BFF-B8CC-6065D9691A2EQ33983793-7850CB6D-2942-47F0-8D23-1DF20CD9618CQ34017377-B90322C8-1F64-454D-86FA-474B8348F2F9Q34789840-8BF67BE4-E7C7-4FF3-9D59-8F1D26F5EDBDQ35235606-17BA3252-ACAA-46F5-9E34-DC4245464BE4Q35434402-A4E37371-5BBB-480F-AB58-F18446FF4005Q35734651-38B91724-860F-42B0-9E70-D641F2A585FAQ35954502-9E1ED4E3-38C8-4727-A4BC-9726D708730CQ36245505-9FD6CB6C-DBE0-4ED4-92B2-A5966EC3909FQ36836467-675C7889-5C0C-4A8E-A02A-0632ADA401B9Q37119212-1AB71ECA-52CD-4610-88D6-269F7B12400AQ37130698-D294D663-0B04-43F7-82F4-37FEB058F741Q37188126-98EF44EE-0DF4-45D5-9202-C8C4F50B77ADQ37827869-E736B1D0-392D-4F6E-B4D4-25F7EA6EAC0BQ37953885-270F9066-02B6-4E5B-9E70-982494F07C64Q38068350-2F5E89D2-11ED-4514-89A4-6023094BFDDFQ38153783-37C84E51-43E5-422D-9B46-6738A5EFAB06Q38153784-F2E88866-4EDF-433F-AEBD-660652835CABQ38262668-9496216D-318C-4977-9DA1-089C35704390Q38331101-7815E406-85C2-4C50-B070-FAC10A59AC5AQ38387683-778B892A-314E-4ED4-A3A4-A25CED406250Q38558645-5BB9DF70-1403-407E-AB40-87DBDAEB1CE6Q38875527-865A5B14-2CBD-4F8E-8F06-85D6DFD491F7Q38894330-8FE36051-E8C7-4BF5-A771-3A4A24DEF9DEQ40099874-8C772A62-6AB2-4B0C-9890-8F1E21C02063Q40385431-EA386FE1-BC2C-4086-B81A-B45EE6AC8893Q41130125-74299C44-FAEA-4322-BC88-BF7FCFC8A3D2Q41613118-9DDECD3F-3B59-40B0-A65F-63E807ADDF7BQ41889254-71D56FC4-162E-4E4B-A291-534FE13C8515Q42126164-E05F60D2-C16D-4512-A069-C924569FFF69Q42322686-6225CDC3-E809-4D69-A105-1168621E1533Q42434360-43DFAE3C-3DAD-4FD5-9A55-38FAEEC4C86AQ43484285-25043D36-BBBD-4124-9D18-383A86E79EB2Q44707694-E0713B2D-F9E4-468D-80B8-A1B9389FE776Q46456558-6CF5F6A2-C65E-4D2C-85D0-3ED3270E28D2
P2860
Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II).
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Five-year follow-up of the Arg ...... ple vessel disease (ERACI II).
@en
Five-year follow-up of the Arg ...... s with multiple vessel disease
@nl
type
label
Five-year follow-up of the Arg ...... ple vessel disease (ERACI II).
@en
Five-year follow-up of the Arg ...... s with multiple vessel disease
@nl
prefLabel
Five-year follow-up of the Arg ...... ple vessel disease (ERACI II).
@en
Five-year follow-up of the Arg ...... s with multiple vessel disease
@nl
P2093
P1476
Five-year follow-up of the Arg ...... ple vessel disease (ERACI II).
@en
P2093
Alejandro Delacasa
Alfredo E Rodriguez
Carlos Fernández Pereira
Daniel Vogel
ERACI II Investigators
Federico Vigo
Igor F Palacios
Jose Navia
Julio Baldi
Máximo Rodriguez Alemparte
P304
P356
10.1016/J.JACC.2004.12.081
P407
P577
2005-08-01T00:00:00Z